Financials Zenicor Medical Systems AB
Equities
ZENI
SE0006343984
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.98 SEK | -1.32% | -.--% | -6.88% |
Valuation
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Capitalization 1 | 106.6 | 115 | 82.29 | 69.32 | 167.4 | 115.5 |
Enterprise Value (EV) 1 | 111.5 | 111.9 | 86.39 | 75.88 | 177.9 | 132.8 |
P/E ratio | -50.2 x | -42.5 x | -47.9 x | 48.6 x | 266 x | -66.1 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 5.85 x | 4.64 x | 3.33 x | 2.98 x | 6.45 x | 3.94 x |
EV / Revenue | 6.12 x | 4.51 x | 3.49 x | 3.26 x | 6.86 x | 4.53 x |
EV / EBITDA | -37.4 x | -47 x | -67.3 x | 41.2 x | 143 x | -184 x |
EV / FCF | -43.7 x | -13 x | -13.2 x | -25.1 x | -42.1 x | -21.6 x |
FCF Yield | -2.29% | -7.71% | -7.6% | -3.98% | -2.38% | -4.64% |
Price to Book | 37.6 x | 6.49 x | 5.15 x | 3.98 x | 9.27 x | 7.09 x |
Nbr of stocks (in thousands) | 4,636 | 5,636 | 5,636 | 5,636 | 5,636 | 5,636 |
Reference price 2 | 23.00 | 20.40 | 14.60 | 12.30 | 29.70 | 20.50 |
Announcement Date | 5/4/18 | 4/29/19 | 4/24/20 | 4/27/21 | 5/3/22 | 4/20/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales 1 | 18.21 | 24.79 | 24.74 | 23.26 | 25.94 | 29.31 |
EBITDA 1 | -2.982 | -2.381 | -1.284 | 1.843 | 1.243 | -0.7216 |
EBIT 1 | -3.033 | -2.468 | -1.373 | 1.788 | 1.214 | -0.7653 |
Operating Margin | -16.65% | -9.95% | -5.55% | 7.68% | 4.68% | -2.61% |
Earnings before Tax (EBT) 1 | -2.126 | -2.704 | -1.718 | 1.426 | 0.6288 | -1.747 |
Net income 1 | -2.126 | -2.704 | -1.718 | 1.426 | 0.6288 | -1.747 |
Net margin | -11.67% | -10.91% | -6.94% | 6.13% | 2.42% | -5.96% |
EPS 2 | -0.4585 | -0.4798 | -0.3048 | 0.2529 | 0.1116 | -0.3100 |
Free Cash Flow 1 | -2.554 | -8.626 | -6.566 | -3.019 | -4.228 | -6.156 |
FCF margin | -14.02% | -34.79% | -26.54% | -12.98% | -16.3% | -21.01% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 5/4/18 | 4/29/19 | 4/24/20 | 4/27/21 | 5/3/22 | 4/20/23 |
Balance Sheet Analysis
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net Debt 1 | 4.91 | - | 4.1 | 6.56 | 10.5 | 17.3 |
Net Cash position 1 | - | 3.08 | - | - | - | - |
Leverage (Debt/EBITDA) | -1.648 x | - | -3.195 x | 3.559 x | 8.465 x | -23.91 x |
Free Cash Flow 1 | -2.55 | -8.63 | -6.57 | -3.02 | -4.23 | -6.16 |
ROE (net income / shareholders' equity) | -54.8% | -26.3% | -10.2% | 8.53% | 3.55% | -10.2% |
ROA (Net income/ Total Assets) | -16.8% | -8.17% | -3.14% | 3.62% | 2.07% | -1.11% |
Assets 1 | 12.68 | 33.09 | 54.73 | 39.41 | 30.43 | 157.7 |
Book Value Per Share 2 | 0.6100 | 3.140 | 2.840 | 3.090 | 3.200 | 2.890 |
Cash Flow per Share 2 | 0.0600 | 1.120 | 0.4800 | 0.2100 | 0.1900 | 0.1000 |
Capex 1 | 0.13 | 0.04 | 0.03 | 0.01 | 0.06 | 4.63 |
Capex / Sales | 0.71% | 0.17% | 0.14% | 0.05% | 0.23% | 15.79% |
Announcement Date | 5/4/18 | 4/29/19 | 4/24/20 | 4/27/21 | 5/3/22 | 4/20/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-6.88% | 2.55M | |
+6.88% | 219B | |
+10.63% | 192B | |
+18.16% | 142B | |
+29.70% | 111B | |
+2.09% | 65.32B | |
+14.14% | 52.45B | |
+3.01% | 49.8B | |
+4.64% | 43.43B | |
+1.45% | 35.95B |
- Stock Market
- Equities
- ZENI Stock
- Financials Zenicor Medical Systems AB